07:02:04 EDT Tue 15 Oct 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Marapharm Ventures Inc
Symbol C : MDM
Shares Issued 108,502,958
Close 2018-06-04 C$ 0.50
Recent Sedar Documents

Marapharm arranges $4.5-million private placement

2018-06-04 11:56 ET - News Release

Ms. Linda Sampson reports

MARAPHARM VENTURES INC. ANNOUNCES $4.5 MILLION NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING

Marapharm Ventures Inc. has arranged a non-brokered private placement of up to nine million units at 50 cents per unit to raise gross proceeds of up to $4.5-million.

The units will consist of one common share of the company and one-half of one common share purchase warrant of the company. Each warrant entitles the holder thereof to purchase one common share of the company at an exercise price of 70 cents for a period of 12 months from the date of issuance of the warrant.

Pursuant to the terms of the warrants, the expiry date of the warrants may be accelerated should the closing price at which the common shares trade exceed 85 cents for five consecutive trading days. Any warrants which remain unexercised after the accelerated expiry date will be cancelled.

The net proceeds raised from the unit offering are intended to be used for further development of the company's Las Vegas project, further development of the company's project in Washington, further development of the company's projects in California and general corporate purposes. The common shares and warrants issued pursuant to the non-brokered offering are subject to a four-month hold period. No finder's fees will be paid in connection with this non-brokered offering.

About Marapharm Ventures Inc.

Marapharm is a publicly traded company investing in the medical and recreational cannabis space since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada and California, and it is seeking expansion opportunities around the world.

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.